Daiwa SB Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-640
Closed -$49K 249
2018
Q3
$49K Buy
640
+110
+21% +$8.31K 0.01% 179
2018
Q2
$38K Buy
530
+50
+10% +$3.53K 0.01% 191
2018
Q1
$36K Sell
480
-50
-9% -$3.98K 0.01% 182
2017
Q4
$38K Buy
+530
New +$40.2K 0.01% 182
2017
Q3
Sell
-380
Closed -$27K 246
2017
Q2
$27K Buy
+380
New +$25.3K 0.01% 190
2017
Q1
Sell
-130
Closed -$9K 257
2016
Q4
$9K Buy
130
+20
+18% +$1.49K ﹤0.01% 198
2016
Q3
$9K Sell
110
-1,260
-92% -$102K ﹤0.01% 189
2016
Q2
$113K Sell
1,370
-24,540
-95% -$2.18M 0.03% 126
2016
Q1
$2.38M Sell
25,910
-383
-1% -$34.5K 0.6% 33
2015
Q4
$2.66M Sell
26,293
-2,387
-8% -$248K 0.62% 37
2015
Q3
$2.82M Buy
28,680
+119
+0.4% +$13.2K 0.64% 41
2015
Q2
$3.34M Sell
28,561
-4,150
-13% -$453K 0.65% 42
2015
Q1
$3.21M Buy
32,711
+21,321
+187% +$2.17M 0.57% 46
2014
Q4
$1.07M Sell
11,390
-39,022
-77% -$4.04M 0.17% 108
2014
Q3
$5.37M Buy
+50,412
New +$4.94M 0.67% 35
2014
Q1
Sell
-1,280
Closed -$96K 134
2013
Q4
$96K Hold
1,280
0.01% 109
2013
Q3
$80K Hold
1,280
0.01% 114
2013
Q2
$66K Buy
+1,280
New +$66.7K 0.01% 127

Other funds holding GILD

Daiwa SB Investments's GILD Position: Q4 2018 in Review

Daiwa SB Investments sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 640 shares — an estimated $49K sold.

Daiwa SB Investments first reported a position in GILD in Q2 2013 and held it in 18 quarters. The position peaked at $5.37M in Q3 2014. 1,497 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Daiwa SB Investments reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Daiwa SB Investments sold 640 Gilead Sciences shares in Q4 2018, an estimated $49K.
  • Daiwa SB Investments first reported a position in Gilead Sciences in Q2 2013 and held it in 18 quarters.
  • Daiwa SB Investments's Gilead Sciences position peaked at $5.37M in Q3 2014.
  • 1,497 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Daiwa SB Investments's 13F filing for Q4 2018, filed 16 Jan 2019.